key: cord-0912571-8q4c1vmf
authors: Arpaci, Ibrahim; Karataş, Kasım; Baloğlu, Mustafa
title: The development and initial tests for the psychometric properties of the COVID-19 Phobia Scale (C19P-S)
date: 2020-05-11
journal: Pers Individ Dif
DOI: 10.1016/j.paid.2020.110108
sha: 5cc049d821a83c0a95e86651941f6da2ffb36592
doc_id: 912571
cord_uid: 8q4c1vmf

Researchers predict that the negative effects of the 2019 novel coronavirus (COVID-19) pandemic will continue to increase. These negative effects are not solely limited to psycho-pathological problems. Serious physiological, social, and economical difficulties due to COVID-19 have already been observed in various nations. In this study, we suggest a new type of specific phobia, which may be categorized under DSM-V 300.29. The current study developed a self-report instrument whose items address the specific phobia diagnosis criteria of the DSM-V and tested its initial psychometric properties. Results show that the scale has initial evidence of construct, convergent, and discriminant validity, and internal consistency reliability. It should be further tested; however, the COVID-19 Phobia Scale (C19P-S) items provide support for assessing the levels of phobia reactions among a wide range of age groups.

J o u r n a l P r e -p r o o f 3 The number of death is still increasing and the COVID-19 virus is not yet fully controlled.

It has been reported that similar epidemics such as H1N1, SARS, MERS, Ebola, and Zika have had serious negative effects and caused fear and anxiety disorders (e.g., Ibrahim, 2016; Kim & Song, 2017; Liu et al., 2005; Tausczik et al. 2012; Theresa et al. 2014 ). During such epidemics, people usually experience various psychological difficulties such as fear, panic, or phobia.

Similarly, the frequent exposure to COVID-19 news in written, visual, and social media increases the levels of anxiety and fear among the public.

It is already reported that the COVID-19 pandemic is increasing the risk of mental disorders including schizophrenia, anxiety, depression, and acute stress disorder among both the healthcare personnel and the public (e.g., Hu et al., 2020; Huang et al., 2020; Huang & Liu, 2020; Li et al., 2020; Liu et al., 2020a; 2020b; Kang et al., 2020; Sun et al., 2020; Xiang et al., 2020) .

At the same time, researchers predict that the negative effects of the COVID-19 pandemic lead to increases in extreme fear of illness, anger, alcohol/tobacco abuse, divorce, and suicide (Dai et al., 2020) .

Phobias are special forms of anxiety disorders defined by a persistent and excessive fear of an object or a situation and are classified into three groups (APA, 2013): Social phobia, agoraphobia, and specific phobia. Five specific phobia types are listed in DSM-V: Natural-J o u r n a l P r e -p r o o f Research indicates that specific phobias are the most psychiatric disorders worldwide (Bandelow & Michaelis, 2015; Wardenaar et al., 2017) . According to the DSM-V criteria, the main characteristic of specific phobias is fear or anxiety limited by the phobia source. If the individual occasionally feels anxious when encountering a particular object or situation, s/he is not to be diagnosed with specific phobia. The response must be different from the usual and temporary fears that are common in society. At the same time, the level of fear or anxiety must be intense. The level of fear may vary depending on the proximity to the object or the situation. However, individuals do not have to show an extreme and meaningless anxiety response in order to be diagnosed with specific phobia. Considering the situation and the environment, the individual's "disproportionate" fear and anxiety response is sufficient for diagnosis (APA, 2013) .

Specific phobias can trigger other anxiety disorders and are reported to comorbid with suicidal tendency, major depression, anxiety disorders, and physical, mental, or mood disorders (Witthauer et al., 2016; Corchs et al., 2006; Ausín et al., 2020; Keyes et al., 2020) .

Specific phobias may emerge depending on the temperamental, genetic, and physiological roots as well as the influence of the environmental conditions (APA, 2013) . In this sense, major man-made catastrophes or natural disasters, such as the COVID-19 pandemic, can be the environmental trigger of phobic conditions. People develop disproportional cognitive, affective, or behavioral responses to the objects and situations that they associate with the COVID-19 J o u r n a l P r e -p r o o f 5 hand, it is often noted in anecdotal experiences that people are afraid of being infected with COVID-19. Previous studies show that natural disasters such as an earthquake or a tsunami; manmade catastrophes such as explosions, wars or terrorism; or epidemics such as MERS, SARS or Ebola lead to detrimental emotions such as phobia, anxiety, depression, hopelessness, and hostility in the short and long terms (Colorado, 2017; Hossain et al., 2020; Steinberg & Daniel, 2020; Qi et al., 2020) . Therefore, as expected, people have already started experiencing phobic reactions in the face of the COVID-19 pandemic. As the pandemic spreads quickly, COVID-19 is expected to lead to increased psycho-pathological problems due to the potential for easy transmission, lack of treatment, and the higher levels of the virus-related deaths (Duan & Zhu, 2020; Gao et al., 2020; Rothan & Byrareddy, 2020) .

Serious negative physiological, social, and economical effects of the COVID-19 pandemic have already been observed in many nations. These negative effects are causing conditions including stress, depression, psycho-somatic, and psycho-social disorders. It is important to detect early sings of COVID-19 phobia in order to provide timely psychological support for individuals who display higher levels of it (Duan & Zhu, 2020; Qiu et al., 2020) .

However, because it is a relatively novel problem, no psychometrically sound assessment is found in the literature to assess the levels of phobia on COVID-19. The American Psychiatric Association (APA) recommends the development of assessment tools adapted to DSM-V criteria for specific phobia disorders. Therefore, the current study aimed to develop a COVID-19 phobia scale (i.e., C19P-S), whose items correspond to the specific phobia (300.29, formerly known as simple phobia) diagnosis criteria of the DSM-V and whose psychometric properties are empirically supported. The C19P-S aims to both contribute to research and enrich future studies on coronavirus. 

The sample of the first study, used for EFA, consisted of 1250 participants (765 women, 61.2%) with a mean age of 37.53 years (SD = 16.94, range =17-89 years). Descriptive statistics calculated for this sample are reported in Table 1 .

[Insert Table 1 about here]

Informed consents were obtained before data collection via Qualtrics. Instructions informed the participants about the study and asked to indicate their level of agreement on the statements from 1 "strongly disagree" to 5 "strongly agree" on a five-point Likert scale.

Various exploratory and confirmatory steps were used in the item development phase.

Relevant literature, including the existing specific phobia scales, and the DSM-V specific phobia criteria (300.29) were analyzed. DSM-V specific phobia diagnosis criterion states that persistent fear of coronavirus is excessive or unreasonable (A); exposure to coronavirus provokes immediate anxiety which may exhibit panic (B); person recognizes that the fear of coronavirus is excessive or unreasonable (C); coronavirus is avoided or else anxiety experienced (D); and people avoid, coronavirus but if they cannot then they feel anxious and such anxiety interferes significantly with their normal routine in occupational or social environments (E).

J o u r n a l P r e -p r o o f 7 Rating ranged from 1 to 10, where 1 indicated that the item did not assess corona phobia at all and should be omitted and 10 indicated that the item measured corona phobia adequately and should be retained.

Items with similar content were combined or redundant items were eliminated. In additions, items which were rated lower than .80 (on average) by the panel were dropped from further investigations. Resulting 70 items were administered online and 1250 participants responded these items. Collected data were subjected to exploratory factor analysis (EFA) and items whose loadings were less than .40 on any of the factors or loaded on more than a single factor were eliminated and the final 20 items were achieved. Finally, 2143 participants responded to 20 items (no one from the first study was included in study II) and data were subjected to confirmatory factor analyses (CFA) for evidence of construct validity. In addition, differences between coronavirus diagnosed and non-diagnosed groups were compared by multivariate analysis of variance (MANOVA) as the evidence of the scale's discriminant validity. As evidence of reliability, internal consistency coefficients were computed.

A total of 102 items generated independently by the researchers were reviewed and rated independently by six specialists (i.e., 2 psychiatrists, 2 psychologist and 2 psychometricians) on a 10-point Likert scale. Specialists' average ratings ranged from 2.14 to 9.83 (mean = 9.16, SD = 1.28). Items rated higher than .80 on average were considered to have adequate face validity.

There were 70 such items retained for exploratory factor analysis.

We conducted EFA with maximum likelihood and varimax rotation to identify the factor structure of the C19P-S. EFA results showed that 50 items were either loaded on more than a single factor and the loading difference was smaller than .20 or failed to load on any single factor (loading < .40). After omitting such 50 items, the final run resulted in a four-factor solution, which accounted for 61.65% of the total variation. The four factors accounted for 16.97%, 16.30%, 16.19%, and 12.19% of the explained variance, respectively. Kaiser measure of sampling adequacy for EFA was .926 and Bartlett test of sphericity was significant, χ 2 (df=190) = 14396.195, p <. 001. All communalities were higher than the threshold of .40. Table 2 shows the rotated factor matrix.

[Insert Table 2 about here]

Tests of normality suggested that kurtosis and skewness coefficients ranged within the threshold values of ±3, and therefore, the data was normally distributed (Table 3) . Cronbach alpha coefficients of the 20 items was .925 and subscale reliabilities ranged from .851 to .903 (Table 3) . Further, correlations among the factors were significant (p < .01) but not so high as to cause concern for multicollinearity (i.e., < .90).

[Insert Table 3 about here] J o u r n a l P r e -p r o o f

The sample of the second study, used for CFA, consisted of 2143 participants (1292 women, 60.3%) with a mean age of 39.66 years (SD = 16.87, range = 12-92 years). Descriptive statistics calculated for the second sample are reported in Table 4 .

[Insert Table 4 about here]

The subscales showed sufficient internal consistency (.853 < α < .897), and Cronbach alpha for the overall scale was .926. Descriptive statistics, skewness, kurtosis, and reliability coefficients are reported in Table 5 .

[Insert Table 5 about here]

Convergent validity was investigated by composite reliability (CR) and average variance extracted (AVE) values. The results show that AVE and CR are higher than the thresholds of .50

and .70, respectively (Fornell & Larcker, 1981) . Thus, convergent validity of the C19P-S evidenced. The results also show that each factor significantly correlated with the other factors (p < .01). Further, all square roots of the AVE values (reported in off-diagonal, Table 6 ) are higher than the cross-correlations; therefore, discriminant validity of the C19P-S is established. Table 6 shows inter-item correlations along with convergent and discriminant validity coefficients.

[Insert Table 6 to .81. Figure 1 shows the measurement model.

[Insert Figure 1 about here]

One-way MANOVA was used to determine whether there was a significant difference in each factor between infected (COVID-19 positive) and randomly selected non-infected groups of subjects. Results showed that there was a statistically significant difference in corona phobia between infected (n = 14) and non-infected subjects (n = 20, randomly selected form n of 2133), 

Emotional responses and coping strategies of nurses and nursing college students during COVID-19 outbreak

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: The latest 2019 novel coronavirus outbreak in Wuhan

Zika virus: Epidemiology, current phobia and preparedness for upcoming mass gatherings, with examples from World Olympics and pilgrimage

The cross-national epidemiology of specific phobia in the World mental health surveys

Associations of specific phobia and its subtypes with physical diseases: An adult community study

Coronavirus disease (COVID-19) pandemic

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese center for disease control and prevention

Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed

After coronavirus pandemic, I do not feel relaxed unless I keep checking up on the supplies

After coronavirus pandemic, I run away from people sneezing

After coronavirus pandemic, I notice that I spend too much time for cleaning my hands

The scores on the scale can range between 20 and 100 and a higher score indicates a greater phobia in the respected subscales and total scale